Last reviewed · How we verify

NCT04949581: SI

Effect Of Bioelectric Therapy On Sternal Instability In Patients With Median Sternotomy After Heart Valve Surgery

Status unknown NA Last updated 2 July 2021
What this trial tests

NA trial testing bioelectric therapy in Heart Valve Surgery in 40 participants. Status unknown.

Timeline
15 July 2021
Primary endpoint
30 September 2021
30 September 2021

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date15 July 2021
Primary completion30 September 2021
Estimated completion30 September 2021

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 40 to 50, any sex, with Heart Valve Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effect of bioelectric therapy on sternal instability in patients with median sternotomy after heart valve surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Heart Valve Surgery

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04949581.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing